LABORATORY CORPORATION OF AMERICA HOLDINGS Laboratory Corporation of America Holdings
Equities
LH
US50540R4092
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 210.4 USD | +1.30% |
|
+4.64% | -7.44% |
Presenter SpeechLisa Gill (Analysts)Good morning. My name is Lisa Gill, and I'm a health care ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Laboratory Corporation of America Holdings is the No. 2 clinical laboratory in the United States. Net sales (including intragroup) break down by activity as follows:
- clinical laboratory services (63.9%): routine testing, patient diagnosis, disease monitoring and treatment, and other services;
- development and clinical trial services (36.1%): for pharmaceutical, biotechnology, medical device and diagnostic companies.
Net sales are distributed geographically as follows : North America (81.2%), Europe (12.7%) and other (6.1%).
Calendar
09:00am
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
210.4
USD
Average target price
239.6
USD
Spread / Average Target
+13.89%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -7.44% | 17.73B | |
| +17.18% | 83.07B | |
| -28.48% | 70.89B | |
| +4.58% | 28.32B | |
| +1.82% | 17.43B | |
| +2.10% | 15.64B | |
| +7.02% | 13.46B | |
| +64.96% | 12.69B | |
| +7.17% | 12.82B | |
| +66.89% | 12.32B |
- Stock Market
- Equities
- LH Stock
- News Laboratory Corporation of America Holdings
- Transcript : Laboratory Corporation of America Holdings Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-12-2021 05
